ReWalk Robotics (NSDQ:RWLK) this week posted fourth-quarter results that missed the consensus on Wall Street.
The Marlborough, Massachusetts-based robotic exoskeleton device maker reported losses of -$3.9 million, or -6¢ per share, on sales of $1.2 million for the three months ended Dec. 31, 2020, for a sales growth of 1.97% compared with Q4 2020.
Earnings per share were 2¢ behind The Street, where analysts were looking for sales of $1.78 million.
“2021 was a foundational year for the company as we made meaningful progress with our efforts to expand access through broad coverage in the United States and Germany. These payment activities combined with new technical developments and the easing of the pandemic restrictions are pivotal elements for our company and this industry in achieving sustainable growth after many years of investment,” CEO Larry Jasinkski said in a news release.
ReWalk Robotics did not provide a financial outlook for fiscal year 2022.
Shares in RWLK were down 6.67% to 98¢ apiece in afternoon trading.